Call the Department of Gastroenterology: 617-726-2426
Explore This Treatment
Overview
This year over 50,000 men and women in the U.S. will die from colon cancer. And many could have been saved. When colon cancer is detected early, there is a 90% survival rate. When it's not, that number is less than 50%. Starting at age 50, you should have a colonoscopy at least once every ten years to screen for polyps and cancer. Colon cancer can be beaten. Prevention and early detection are your best weapons.
We offer the most advanced colon cancer screenings and treatments available. Our world-renowned specialists can provide the comprehensive care and peace of mind you'll only find at one of the world's leading hospitals.
Talk to your doctor about scheduling your colorectal cancer screening at Massachusetts General Hospital. Then call (617) 726-2426 or request an appointment online.
Please visit our doctors page for a list of our gastroenterologists.
Other Options for Colorectal Cancer Screening
Understanding the different CRC screening options, including home-based stool tests and colonoscopy, depends on the individual risk of colon cancer and the patient’s preferences. Patients can explore and compare the benefits, harms, and risks of each option as they make an informed decision about what matters most to them.
The below sheet describes three screening options that are reasonable for most people: schedule a colonoscopy, have a stool-based test, or delay your colonoscopy for a year.
Colorectal Cancer Screening Shared-Decision Worksheet English | Español
Colonoscopy Risks and Benefits
A colonoscopy is a procedure that involves an examination of the entire colon and requires bowel preparation and sedation. Watch this video to learn about the purpose and benefits of the exam, how the colonoscopy procedure is performed, and the potential risks and complications.
Andrew Chan, MD, MPH is co-leading the global team known as PROSPECT, which received a grant of up to $25m over five years, to study early-onset colorectal cancer from Cancer Grand Challenges after an international competition.
We reached out to investigators at Massachusetts General Hospital and asked them to give us one science-backed action people can take to improve their heart health.
In a nationally representative of US adults with self-reported chronic liver disease (CLD), approximately 308,000 (6%) identified delaying medical care due to transportation barriers.
Michael Dougan, MD, PhD, is a senior author of a new study in Clinical Gastroenterology and Hepatology, Tofacitinib Is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.
In this 12-month, placebo-controlled, randomized clinical trial of 26 well-treated persons with HIV without known CVD, eplerenone was associated with a significant reduction in arterial inflammation.